Home
Mail
Search
News
Finance
Sport
Lifestyle
Celebrity
Movies
Weather
Mobile
More
Yahoo
Mail
Cryptocurrencies
News
Property
Money
Markets
Industries
Watchlists
My Portfolio
My Screeners
Singapore markets close in 5 hours 45 minutes
Straits Times Index
3,337.52
+4.72
(+0.14%)
Nikkei
39,687.40
+104.32
(+0.26%)
Hang Seng
17,718.61
+2.11
(+0.01%)
FTSE 100
8,164.12
-15.56
(-0.19%)
Bitcoin USD
63,384.32
+2,630.37
(+4.33%)
CMC Crypto 200
1,314.73
+30.90
(+2.41%)
Shanghai Allist Pharmaceuticals Co., Ltd. (688578.SS)
Shanghai - Shanghai Delayed price. Currency in CNY
Add to watchlist
63.61
-0.13
(-0.20%)
As of 11:00AM CST. Market open.
Summary
Chart
Statistics
Historical data
Profile
Financials
Analysis
Options
Holders
Sustainability
Show
:
Income statement
Balance sheet
Cash flow
Annual
Quarterly
Income statement
All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
2,484,513
2,018,183
791,002
530,094
560.8871
Cost of revenue
103,430
77,873
31,719
5,645
161.6941
Gross profit
2,381,083
1,940,309
759,283
524,449
399.193
Operating expenses
Research development
313,650
313,059
191,750
222,595
177,963
Selling general and administrative
1,107,756
943,407
447,390
283,710
111,878
Total operating expenses
1,544,991
1,370,379
713,012
573,972
338,970
Operating income or loss
836,093
569,930
46,271
-49,523
-338,571
Interest expense
126.9925
160.7869
325.323
605.0513
1,145
Income before tax
933,435
656,221
125,999
18,275
-310,515
Income tax expense
18,085
12,046
-4,522
-
-
Income from continuing operations
915,350
644,175
130,521
18,275
-310,515
Net income
915,350
644,175
130,521
18,275
-310,515
Net income available to common shareholders
915,350
644,175
130,521
18,275
-310,515
Basic EPS
1.08
1.43
0.29
0.04
-0.84
Diluted EPS
1.08
1.43
0.29
0.04
-0.84
Basic average shares
451,258
450,472
450,071
456,864
369,661
Diluted average shares
451,258
450,472
450,071
456,864
369,661
Data disclaimer
Help
Suggestions
Terms
and
Privacy Policy
Privacy dashboard
About our ads
© 2024 Yahoo. All rights reserved.